Use of comparative genomics approaches to characterize interspecies differences in response to environmental chemicals: Challenges, opportunities, and research needs

Abstract

A critical challenge for environmental chemical risk assessment is the characterization and reduction of uncertainties introduced when extrapolating inferences from one species to another. The purpose of this article is to explore the challenges, opportunities, and research needs surrounding the issue of how genomics data and computational and systems level approaches can be applied to inform differences in response to environmental chemical exposure across species. We propose that the data, tools, and evolutionary framework of comparative genomics be adapted to inform interspecies differences in chemical mechanisms of action. We compare and contrast existing approaches, from disciplines as varied as evolutionary biology, systems biology, mathematics, and computer science, that can be used, modified, and combined in new ways to discover and characterize interspecies differences in chemical mechanism of action which, in turn, can be explored for application to risk assessment. We consider how genetic, protein, pathway, and network information can be interrogated from an evolutionary biology perspective to effectively characterize variations in biological processes of toxicological relevance among organisms. We conclude that comparative genomics approaches show promise for characterizing interspecies differences in mechanisms of action, and further, for improving our understanding of the uncertainties inherent in extrapolating inferences across species in both ecological and human health risk assessment. To achieve long-term relevance and consistent use in environmental chemical risk assessment, improved bioinformatics tools, computational methods robust to data gaps, and quantitative approaches for conducting extrapolations across species are critically needed. Specific areas ripe for research to address these needs are recommended.

A risk assessment-driven quantitative comparison of gene expression profiles in PBMCs and white adipose tissue of humans and rats after isoflavone supplementation

“…breast and uterus, and dose-response data would be needed. While the use of gene expression data in risk assessment is increasing, and discussions are still ongoing regarding the most appropriate use of this data Burgess-Herbert & Euling, 2013), further quantitative evaluation of similarities and differences between tissues and species could be a step forward towards reducing uncertainty and variability in risk assessment practices.…”

“…These often regard qualitative and semi-quantitative approaches , while quantitative approaches could enable better comparison between tissues and species and advance the use of gene expression in risk assessment (Burgess-Herbert & Euling, 2013;Chepelev et al, 2015) .…”

Endocrinology: Advances through omics and related technologies

“…This approach was based on synteny group search, a tool for evolutionary understanding and genome rearrangement identification such as duplication or reorientation events between species. By comparison and identification of similarity in genes and genomics, one can then infer functional relationships to aid in determining whether or not endocrine pathways are conserved across species (Burgess-Herbert and Euling, 2011). However, despite this advancement, not all genes, proteins, or metabolites can be identified and are therefore not interpreted.…”

A genomics-based framework for identifying biomarkers of human neurodevelopmental toxicity

“…There are wellrecognized differences in embryonic development [6], ESC properties [7] and chemicalsensitivity [8] between rodents and humans. Therefore, hESC models offer advantages over rodent ESCs for human hazard assessment, enabling extrapolation of data to our species.…”